Pediatric and Geriatric Article Archive CD from the International Journal of Pharmaceutical Compounding

Sign On

PEDIATRICS AND GERIATRICS

Permanent storage and easy retrieval of Journal articles and formulations.
  - Includes the full-color, searchable, PDF files of articles and formulations from the Journal.
  - Print Journal articles in color for your research and marketing needs.
  - Eliminate long searches through past issues for articles and formulations.

Only $95.00

(Select Format)

This archive contains the following articles listed by volume, issue and page number:

Title (Click for Details)	Vol/Issue	Page

PEDIATRICS RELATED ARTICLES
PreScription: Standardized Concentrations: Pro or Con?	Vol. 22 No. 6	444
Current Trends and Emerging Priorities in Compounded Preparations for Children	Vol. 22 No. 5	358
Stability of Dalteparin 1,000 Unit/mL in 0.9% Sodium Chloride for Injection in Polypropylene Syringes	Vol. 21 No. 5	426
Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas	Vol. 21 No. 4	282
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules	Vol. 21 No. 2	171
Case Report: Pediatric Scar Management After Open-heart Surgery	Vol. 20 No. 4	277
Extended Stability of Morphine and Sildenafil for Oral Use in Infants and Young Children	Vol. 20 No. 3	247
Development of Extemporaneously Compounded Aripiprazole Oral Suspensions for Use in Children	Vol. 20 No. 3	257
Extemporaneous Compounding of Oral Acitretin Suspension for Pediatric Patient with Generalized Pustular Psoriasis	Vol. 20 No. 1	6
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls	Vol. 19 No. 3	205
L-Cysteine Hydrochloride 50-mg/mL Injection	Vol. 19 No. 2	146
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition	Vol. 18 No. 5	427
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013	Vol. 18 No. 1	6
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2	Vol. 17 No. 6	446
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms	Vol. 17 No. 5	364
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1	Vol. 17 No. 5	388
Indomethacin 1-mg/mL Injection	Vol. 17 No. 5	419
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment	Vol. 17 No. 5	432
Pediatric Health Care: An Introduction	Vol. 17 No. 1	6
A Concise Discussion of Headache Types, Part 3: Migraine	Vol. 16 No. 4	270
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients	Vol. 15 No. 6	446
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers	Vol. 15 No. 6	458
Diaper Rash Relief: Common Sense Remedies and Treatments	Vol. 15 No. 6	464
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride	Vol. 15 No. 5	358
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient	Vol. 15 No. 5	386
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient	Vol. 15 No. 4	316
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient	Vol. 15 No. 3	194
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration	Vol. 15 No. 3	200
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease	Vol. 15 No. 2	124
Acetylcysteine 1% or 10% Oral Solution	Vol. 15 No. 2	156
Glutathione 25% in Pluronic Lecithin Organogel	Vol. 14 No. 6	518
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together	Vol. 14 No. 4	270
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet	Vol. 14 No. 1	21
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis	Vol. 14 No. 1	40
When Traditional Medicine Fails	Vol. 14 No. 1	6
Calculations	Vol. 14 No. 1	58
Emanuel Butt Paste	Vol. 13 No. 5	431
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding	Vol. 13 No. 4	314
Compounding Naltrexone for the Treatment of Autism	Vol. 13 No. 4	296
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report	Vol. 13 No. 3	220
Compounding for Pediatric Patients: Case Reports and Formulations	Vol. 13 No. 1	6
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports	Vol. 13 No. 1	14
Calculations	Vol. 13 No. 1	63
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets	Vol. 13 No. 1	64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder	Vol. 13 No. 1	65
Diaper Rash Cream with Miconazole	Vol. 13 No. 1	68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches	Vol. 13 No. 1	69
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada	Vol. 12 No. 4	365
Benzyl Benzoate Lotion	Vol. 12 No. 3	261
Valsartan 4-mg/mL Oral Liquid	Vol. 12 No. 3	269
Trimethoprim 10-mg/mL Oral Suspension	Vol. 12 No. 1	73
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2	Vol. 11 No. 3	220
Methylphenidate 1-mg/mL Oral Liquid	Vol. 11 No. 3	249
Challenges of Compounding for Patients on the Ketogenic Diet	Vol. 11 No. 2	116
Ranitidine Hydrochloride 15-mg/mL Oral Liquid	Vol. 11 No. 2	161
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development—Pediatric Formulations Initiative, Part 1	Vol. 11 No. 1	5
Principles of Pediatric Palliative Care and Pain Control	Vol. 11 No. 1	10
Pediatric Oral Formulations: A Continual Challenge	Vol. 11 No. 1	17
Sevelamer Suspension in Children with End-Stage Renal Disease	Vol. 11 No. 1	20
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis	Vol. 11 No. 1	26
Case Report: Treatment of Labial Adhesions in a Child	Vol. 11 No. 1	27
Calculations	Vol. 11 No. 1	68
Caffeine Citrate 10-mg/mL Oral Liquid	Vol. 11 No. 1	69
Carbidopa 1.25-mg/mL Oral Liquid	Vol. 11 No. 1	70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid	Vol. 11 No. 1	71
Methyldopa 25-mg/mL Oral Liquid	Vol. 11 No. 1	75
Metolazone 1-mg/mL Oral Liquid	Vol. 11 No. 1	76
Prednisone 10-mg/mL Oral Liquid	Vol. 11 No. 1	77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid	Vol. 11 No. 1	78
Nitrazepam 1-mg/mL Oral Liquid	Vol. 10 No. 5	388
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund)	Vol. 10 No. 5	390
Adderall 1-mg/mL Oral Liquid	Vol. 10 No. 4	299
Lisinopril 1-mg/mL Oral Liquid	Vol. 10 No. 4	302
Nifedipine 4-mg/mL Oral Liquid	Vol. 10 No. 4	303
Propranolol Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 4	304
Propylthiouracil 5-mg/mL Oral Liquid	Vol. 10 No. 1	67
Prescription: Pediatric Formulation Initiatives	Vol. 9 No. 6	410
Unlocking Autism: Is Compounding the Key?	Vol. 9 No. 6	413
Compounding for a Pediatric Hospital	Vol. 9 No. 6	423
Wiping Out Diaper Rash	Vol. 9 No. 6	433
Pediatric Oral Liquid Preparations	Vol. 9 No. 6	437
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions	Vol. 9 No. 6	456
PostScription: Compounding Pharmacies and the Successful Treatment of Autism	Vol. 9 No. 6	487
Calculations	Vol. 9 No. 1	57
Stability of an Extemporaneously Compounded Propylthiouracil Suspension	Vol. 9 No. 1	82
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid	Vol. 8 No. 6	458
Domperidone in Lactation: Use as a Galactagogue	Vol. 8 No. 5	329
Head to Toe Solutions: A Quick Review of Current Therapies	Vol. 8 No. 5	345
Book and Literature Reviews	Vol. 8 No. 4	244
Gag Tablet Lollipops	Vol. 8 No. 3	184
Amiodarone HCl 5-mg/mL Oral Liquid	Vol. 8 No. 3	214
Atenolol 2-mg/mL Oral Liquid	Vol. 8 No. 3	215
Glycopyrrolate 0.5-mg/mL Oral Liquid	Vol. 8 No. 3	218
Flucytosine 10-mg/mL Oral Liquid	Vol. 8 No. 2	134
Griseofulvin 25-mg/mL Oral Liquid	Vol. 8 No. 2	135
Stomatitis Mouthwash	Vol. 8 No. 2	140
Tacrolimus 0.5-mg/mL Oral Liquid	Vol. 8 No. 2	141
Tiagabine 1-mg/mL Oral Liquid	Vol. 8 No. 2	142
Sulfasalazine 250-mg/5-mL Oral Liquid	Vol. 7 No. 6	474
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension	Vol. 7 No. 6	485
Thioridazine HCl 100-mg/mL Concentrated Solution	Vol. 7 No. 5	381
Isoniazid 10-mg/mL Oral Solution	Vol. 7 No. 5	376
Ursodiol 150-mg Capsules	Vol. 7 No. 5	382
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride	Vol. 7 No. 5	389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings	Vol. 7 No. 5	394
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations	Vol. 7 No. 4	313
Pediatric Dermatitis	Vol. 6 No. 6	419
Excerpts from and Reviews of Current Published Literature: Pediatric Medications	Vol. 6 No. 6	423
Book Reviews: Compounding for Pediatric Patients	Vol. 6 No. 6	424
Caffeine and Sodium Benzoate 250-mg/mL Injection	Vol. 6 No. 6	449
Dimenhydrinate 50-mg/mL Injection	Vol. 6 No. 6	451
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid	Vol. 6 No. 5	367
Topical Secretin for the Treatment of Autism	Vol. 5 No. 6	436
Basics of Compounding: Suspensions	Vol. 5 No. 4	294
Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Sugar-Free Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Spironolactone Oral Suspension 2-mg/mL	Vol. 5 No. 4	297
Progesterone Oral Suspension 40-mg/mL	Vol. 5 No. 4	297
Xanthan Gum Oral Suspension Vehicle 0.3%	Vol. 5 No. 4	297
Pediatric Preoperative Cocktail Injection	Vol. 5 No. 4	306
The Basics of Compounding Emulsions, Part 2	Vol. 5 No. 3	198
The Basics of Compounding Emulsions, Part 1	Vol. 5 No. 2	120
Pediatric Compounding: Coloring Outside the Lines	Vol. 5 No. 1	6
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients	Vol. 5 No. 1	9
Flavoring: Compounding a Treat	Vol. 5 No. 1	13
Autism in Children	Vol. 5 No. 1	18
Methylphenidate in the Treatment of Attention Deficit Disorders	Vol. 5 No. 1	21
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature	Vol. 5 No. 1	23
Compounding in History: Pediatric Considerations	Vol. 5 No. 1	30
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations	Vol. 5 No. 1	38
Cholestyramine 6.5% Ointment	Vol. 5 No. 1	42
Ivermectin 0.8% Creme Rinse	Vol. 5 No. 1	43
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel	Vol. 5 No. 1	44
Lorazepam 1-mg Chewable Gummy Gels	Vol. 5 No. 1	45
Metronidazole Benzoate 400-mg/5-mL Oral Suspension	Vol. 5 No. 1	46
Natural Head Lice Repellant Spray	Vol. 5 No. 1	48
Niacinamide 4% Acne Gel	Vol. 5 No. 1	49
Promethazine HCl 50-mg/mL in PLO Gel	Vol. 5 No. 1	51
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations	Vol. 4 No. 4	289
Ondansetron HCl 8-mg/mL in PLO	Vol. 4 No. 4	305
Compounding Ear, Nose and Throat Preparations	Vol. 4 No. 3	164
Xylitol in the Prevention of Otitis Media	Vol. 4 No. 3	171
Sildenafil 0.2% Otic Drops	Vol. 4 No. 3	175
Amphotericin B 100-mg Troches	Vol. 4 No. 3	208
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles	Vol. 4 No. 3	214
Basics of Compounding: Compounding Solutions	Vol. 4 No. 2	122
Sugar-Free Suspension Structured Vehicle, USP	Vol. 4 No. 2	136
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops	Vol. 3 No. 6	461
Linguet Base (Soft Lozenge)	Vol. 3 No. 6	462
Sorbitol Based Hard Lozenges	Vol. 3 No. 6	462
Sucrose Based Hard Lozenges	Vol. 3 No. 6	462
Polyethylene Glycol (PEG) Troches (Soft Lozenges)	Vol. 3 No. 6	463
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges)	Vol. 3 No. 6	463
Chewable Lozenges	Vol. 3 No. 6	464
Methotrexate 2.5-mg/5-mL Oral Liquid	Vol. 3 No. 6	474
Extemporaneous Formulations in Pediatric Patients	Vol. 3 No. 4	274
Analysis of Extemporaneous Alprostadil Formulations	Vol. 3 No. 2	148
Oral Ulceration Mouthwash	Vol. 3 No. 1	10
Alternatives for the Lactose-Intolerant Patient	Vol. 2 No. 6	412
Pediatric Central Parenteral Nutrition Solution	Vol. 2 No. 5	368
Pediatric Central Parenteral Nutrition Solution with Heparin	Vol. 2 No. 5	369
Pediatric Peripheral Parenteral Nutrition Solution	Vol. 2 No. 5	370
Malathion Topical Lotion: Therapy for Resistant Head Lice	Vol. 2 No. 4	268
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration	Vol. 2 No. 4	318
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel	Vol. 2 No. 2	159
Vehicles for Compounding Oral Liquids: Some Practical Considerations	Vol. 2 No. 2	160
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane	Vol. 2 No. 1	83
Ketoconazole 20-mg/mL Oral Liquid	Vol. 1 No. 6	414
Baclofen 10-mg/mL Oral Liquid	Vol. 1 No. 5	321
Captopril 0.75-mg/mL Oral Liquid	Vol. 1 No. 5	322
Diltiazem HCl 12-mg/mL Oral Suspension	Vol. 1 No. 5	323
Stability of Bethanechol Chloride Oral Liquid Dosage Forms	Vol. 1 No. 4	278
Allopurinol 20-mg/mL Oral Liquid	Vol. 1 No. 3	174
Dipyridamole 10-mg/mL Oral Liquid	Vol. 1 No. 3	176
Labetalol HCl 40-mg/mL Oral Liquid	Vol. 1 No. 3	179
Metoprolol Tartrate 10-mg/mL Oral Liquid	Vol. 1 No. 3	180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid	Vol. 1 No. 3	183
Spironolactone 25-mg/mL Oral Liquid	Vol. 1 No. 3	184
Verapamil HCl 50-mg/mL Oral Liquid	Vol. 1 No. 3	188
The Formulation Development and Stability of Spironolactone Suspension	Vol. 1 No. 3	195
The Formulation Development and Stability of Metronidazole Suspension	Vol. 1 No. 3	200
Metronidazole 15-mg/mL Suspension	Vol. 1 No. 3	202
Compounding for the Pediatric Patient	Vol. 1 No. 2	84
Attention Deficit Hyperactivity Disorder	Vol. 1 No. 2	87
Flavors and Flavoring	Vol. 1 No. 2	90
Compounded Suppositories and Pharmaceutical Care	Vol. 1 No. 2	93
Acetazolamide 25-mg/mL Oral Liquid	Vol. 1 No. 2	101
Azathioprine 50-mg/mL Oral Liquid	Vol. 1 No. 2	102
Flecainide Acetate 20-mg/mL Oral Liquid	Vol. 1 No. 2	103
Methylcellulose 1% to 5% Solutions	Vol. 1 No. 2	104
Methylcellulose Oral-Liquid Vehicles	Vol. 1 No. 2	105
Pediatric Chewable Gummy Gel Base	Vol. 1 No. 2	106
Pediatric Chocolate Troche Base	Vol. 1 No. 2	106
Pediatric Chewable Gummy Gels	Vol. 1 No. 2	107
Pediatric Chocolate Troche	Vol. 1 No. 2	108
Nystatin Popsicles	Vol. 1 No. 2	109
Procainamide HCl 50-mg/mL Oral Liquid	Vol. 1 No. 2	110
Syrup NF	Vol. 1 No. 2	111
Tetracaine 20-mg Lollipops	Vol. 1 No. 2	112
Tetracycline Compound Troche	Vol. 1 No. 2	113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%)	Vol. 1 No. 2	114
Omeprazole (Prilosec) in the Atypical Patient, Administration of	Vol. 1 No. 1	13
HDDM Hard Troche	Vol. 1 No. 1	29
HDDM Soft Troche	Vol. 1 No. 1	30
HDDM Sugar Troche	Vol. 1 No. 1	30
Metoclophen Nausea Suppositories	Vol. 1 No. 1	31
Metoclophen-Modified Nausea Suppositories	Vol. 1 No. 1	31
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets	Vol. 1 No. 1	60

Title (Click for Details)	Vol/Issue	Page

GERIATRICS RELATED ARTICLES
Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules	Vol. 21 No. 2	171
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review	Vol. 19 No. 1	6
Treatment Options for Male Hypogonadism	Vol. 17 No. 1	28
Testosterone Levels in an Aging Population: Screen, Measure, and Restore	Vol. 15 No. 2	102
Clozapine 20-mg/mL Oral Suspension	Vol. 14 No. 3	243
PreScription: The Ages of Man	Vol. 14 No. 2	92
Emerging Evidence for Androgen Replacement Therapy in Aging Men	Vol. 14 No. 2	94
PreScription: Geriatric Compounding: An Opportunity for Pharmacists	Vol. 13 No. 6	492
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male	Vol. 13 No. 6	494
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms	Vol. 13 No. 6	498
Marketing the Geriatric Patient	Vol. 13 No. 6	538
Calculations	Vol. 13 No. 6	545
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil	Vol. 13 No. 4	340
Arthritis Epidemiology Impacts Pharmacists	Vol. 12 No. 6	476
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration	Vol. 12 No. 1	8
Calculations	Vol. 11 No. 1	68
Carbidopa 1.25-mg/mL Oral Liquid	Vol. 11 No. 1	70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid	Vol. 11 No. 1	71
Methyldopa 25-mg/mL Oral Liquid	Vol. 11 No. 1	75
Metolazone 1-mg/mL Oral Liquid	Vol. 11 No. 1	76
Propranolol Hydrochloride 1-mg/mL Oral Liquid	Vol. 10 No. 4	304
Stability of an Extemporaneously Compounded Propylthiouracil Suspension	Vol. 9 No. 1	82
Book and Literature Reviews	Vol. 8 No. 4	244
Case Report: Wound Care of a Diabetic Foot Ulcer	Vol. 8 No. 4	265
Current Topical Treatments in Wound Healing - Part 1	Vol. 8 No. 4	269
Atropine 1-mg Gelatin Troches	Vol. 8 No. 3	184
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO)	Vol. 8 No. 3	185
Pain Management in the Elderly	Vol. 8 No. 3	187
Amiodarone HCl 5-mg/mL Oral Liquid	Vol. 8 No. 3	214
Atenolol 2-mg/mL Oral Liquid	Vol. 8 No. 3	215
Glycopyrrolate 0.5-mg/mL Oral Liquid	Vol. 8 No. 3	218
Flucytosine 10-mg/mL Oral Liquid	Vol. 8 No. 2	134
Griseofulvin 25-mg/mL Oral Liquid	Vol. 8 No. 2	135
Stomatitis Mouthwash	Vol. 8 No. 2	140
Tacrolimus 0.5-mg/mL Oral Liquid	Vol. 8 No. 2	141
Tiagabine 1-mg/mL Oral Liquid	Vol. 8 No. 2	142
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution	Vol. 8 No. 2	147
Ergoloid Mesylate 1-mg/mL Oral Liquid	Vol. 7 No. 6	470
Perphenazine 2.5-mg/5-mL Syrup	Vol. 7 No. 6	473
Sulfasalazine 250-mg/5-mL Oral Liquid	Vol. 7 No. 6	474
Thioridazine HCl 100-mg/mL Concentrated Solution	Vol. 7 No. 5	381
Isoniazid 10-mg/mL Oral Solution	Vol. 7 No. 5	376
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride	Vol. 7 No. 5	389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings	Vol. 7 No. 5	394
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations	Vol. 7 No. 4	313
Levofloxacin 250-mg/5mL Oral Liquid	Vol. 7 No. 1	60
Ofloxacin 250-mg/5-mL Oral Liquid	Vol. 7 No. 1	60
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid	Vol. 6 No. 5	367
Compounding for Geriatrics Patients	Vol. 6 No. 3	168
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease	Vol. 6 No. 3	171
Book Reviews: Wellness, Nutrition and Geriatrics	Vol. 6 No. 3	180
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension	Vol. 6 No. 3	202
Mild Laxative	Vol. 6 No. 3	185
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel	Vol. 6 No. 3	185
Bioidentical Hormones in the Treatment of Osteoporosis	Vol. 5 No. 5	339
Basics of Compounding: Suspensions	Vol. 5 No. 4	294
Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Sugar-Free Suspension Structured Vehicle, USP	Vol. 5 No. 4	296
Spironolactone Oral Suspension 2-mg/mL	Vol. 5 No. 4	297
Progesterone Oral Suspension 40-mg/mL	Vol. 5 No. 4	297
Xanthan Gum Oral Suspension Vehicle 0.3%	Vol. 5 No. 4	297
The Basics of Compounding Emulsions, Part 2	Vol. 5 No. 3	198
The Basics of Compounding Emulsions, Part 1	Vol. 5 No. 2	120
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations	Vol. 5 No. 1	38
Milk of Magnesia Concentrate, Unflavored	Vol. 5 No. 1	47
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease	Vol. 4 No. 4	276
Amphotericin B 100-mg Troches	Vol. 4 No. 3	208
Saliva Substitute for Dry Mouth/Throat	Vol. 4 No. 3	215
Basics of Compounding: Compounding Solutions	Vol. 4 No. 2	122
Osteoarthritis: Other Options	Vol. 3 No. 6	433
Methotrexate 2.5-mg/5-mL Oral Liquid	Vol. 3 No. 6	474
Alternatives for the Lactose-Intolerant Patient	Vol. 2 No. 6	412
Treatment of Skin Aging with Topical Estrogens	Vol. 2 No. 4	270
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form	Vol. 2 No. 4	314
Vehicles for Compounding Oral Liquids: Some Practical Considerations	Vol. 2 No. 2	160
Estrogen in the Treatment and Prevention of Alzheimer's Disease	Vol. 2 No. 1	24
Ketoconazole 20-mg/mL Oral Liquid	Vol. 1 No. 6	414
Baclofen 10-mg/mL Oral Liquid	Vol. 1 No. 5	321
Captopril 0.75-mg/mL Oral Liquid	Vol. 1 No. 5	322
Diltiazem HCl 12-mg/mL Oral Suspension	Vol. 1 No. 5	323
Metolazone 1-mg/mL Oral Suspension	Vol. 1 No. 5	329
Stability of Bethanechol Chloride Oral Liquid Dosage Forms	Vol. 1 No. 4	278
Creative Compounding for the Geriatric Patient	Vol. 1 No. 3	147
Drug Products and Drug Packaging for the Elderly	Vol. 1 No. 3	150
Common Diseases of the Elderly	Vol. 1 No. 3	152
Allopurinol 20-mg/mL Oral Liquid	Vol. 1 No. 3	174
Dipyridamole 10-mg/mL Oral Liquid	Vol. 1 No. 3	176
Labetalol HCl 40-mg/mL Oral Liquid	Vol. 1 No. 3	179
Metoprolol Tartrate 10-mg/mL Oral Liquid	Vol. 1 No. 3	180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid	Vol. 1 No. 3	183
Spironolactone 25-mg/mL Oral Liquid	Vol. 1 No. 3	184
Verapamil HCl 50-mg/mL Oral Liquid	Vol. 1 No. 3	188
Metronidazole 15-mg/mL Suspension	Vol. 1 No. 3	202
Acetazolamide 25-mg/mL Oral Liquid	Vol. 1 No. 2	101
Azathioprine 50-mg/mL Oral Liquid	Vol. 1 No. 2	102
Flecainide Acetate 20-mg/mL Oral Liquid	Vol. 1 No. 2	103
Methylcellulose 1% to 5% Solutions	Vol. 1 No. 2	104
Methylcellulose Oral-Liquid Vehicles	Vol. 1 No. 2	105
Procainamide HCl 50-mg/mL Oral Liquid	Vol. 1 No. 2	110
Syrup NF	Vol. 1 No. 2	111
Tetracaine 20-mg Lollipops	Vol. 1 No. 2	112
Tetracycline Compound Troche	Vol. 1 No. 2	113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%)	Vol. 1 No. 2	114
Stability of Allopurinol Suspension Compounded from Tablets	Vol. 1 No. 2	128
Hospice Care and the Pharmacist	Vol. 1 No. 1	11
Omeprazole (Prilosec) in the Atypical Patient, Administration of	Vol. 1 No. 1	13
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup Compounded from Commercial Tablets	Vol. 1 No. 1	60

	Instant PDF Download
	Mailed CD